Description

Background:

Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis.

Product datasheet:

Overview

Product Description  
Species ReactivitiesHuman,Mouse,Rat
ImmunogenSynthesized peptide derived from human p53 around the phosphorylation site of T18.

Properties

FormLiquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Storage Instructions-20°C/1 year
ClonalityPolyclonal

References:

  1. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.
    Zakut-Houri R., Bienz-Tadmor B., Givol D., Oren M.
    EMBO J. 4:1251-1255(1985) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
  2. Characterization of the human p53 gene.
    Lamb P., Crawford L.
    Mol. Cell. Biol. 6:1379-1385(1986) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANT GLY-76.
  3. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.
    Harlow E., Williamson N.M., Ralston R., Helfman D.M., Adams T.E.
    Mol. Cell. Biol. 5:1601-1610(1985) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
  4. Molecular basis for heterogeneity of the human p53 protein.
    Harris N., Brill E., Shohat O., Prokocimer M., Wolf D., Arai N., Rotter V.
    Mol. Cell. Biol. 6:4650-4656(1986) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
  5. A variation in the structure of the protein-coding region of the human p53 gene.
    Buchman V.L., Chumakov P.M., Ninkina N.N., Samarina O.P., Georgiev G.P.
    Gene 70:245-252(1988) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
  6. p53 is frequently mutated in Burkitt’s lymphoma cell lines.
    Farrell P.J., Allan G., Shanahan F., Vousden K.H., Crook T.
    EMBO J. 10:2879-2887(1991) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS SPORADIC CANCERS.
  7. Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs.
    Allalunis-Turner M.J., Barron G.M., Day R.S. III, Dobler K.D., Mirzayans R.
    Radiat. Res. 134:349-354(1993) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT LYS-286.
  8. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
    Chang N.-S., Pratt N., Heath J., Schultz L., Sleve D., Carey G.B., Zevotek N.
    J. Biol. Chem. 276:3361-3370(2001) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH WWOX.
  9. p53 isoforms can regulate p53 transcriptional activity.
    Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., Lane D.P.
    Genes Dev. 19:2122-2137(2005) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 7; 8 AND 9), SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ALTERNATIVE PROMOTER USAGE, ALTERNATIVE SPLICING, INDUCTION, VARIANT ARG-72. Tissue: Colon.
  10. Chumakov P.M., Almazov V.P., Jenkins J.R.
    Submitted (JUN-1991) to the EMBL/GenBank/DDBJ databasesCited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
external
sizechest(in.)waist(in.)hips(in.)
XS34-3627-2934.5-36.5
S36-3829-3136.5-38.5
M38-4031-3338.5-40.5
L40-4233-3640.5-43.5
XL42-4536-4043.5-47.5
XXL45-4840-4447.5-51.5

Reviews

There are no reviews yet.


Be the first to review “Phospho-p53 (T18) Polyclonal Antibody, 100 µg, (ATB-P0212)”